Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial of Poly-ICLC in the Management of Recurrent Pediatric Low Grade Gliomas

NCT01188096 is registered in ClinicalTrials.gov with Wake Forest University Health Sciences as lead sponsor.

NCT NCT01188096
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01188096 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial of Poly-ICLC in the Management of Recurrent Pediatric Low Grade Gliomas
Lead sponsor
Wake Forest University Health Sciences
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2010
Completion date
July 31, 2019
Enrollment
23 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

brain tumors